TrialMedical oncology (Northwood, London, England)2015

An open-label, randomized, multicenter dose-finding study of once-per-cycle pegfilgrastim versus daily filgrastim in Chinese breast cancer patients receiving TAC chemotherapy.

Wei Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.